Searched for
ALEMBIC PHARMACEUTICALS STOCK
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Midcap stock zooms 9% on receiving USFDA approval for glaucoma drugBrimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressu...
- Hold Alembic Pharmaceuticals, target price Rs 660: JM FinancialJM Financial has reduced its earnings by 10% in FY24/25 adjusting for higher costs, depreciation and lower other income.
- Buy Alembic Pharmaceuticals, target price Rs 653: ICICI SecuritiesAlembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 10695.00 Crore) operating in Pharma...
- Hold Alembic Pharmaceuticals, target price Rs 730: JM FinancialAlembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 11514.67 Crore) operating in Pharma...
- Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...
- Reduce Alembic Pharmaceuticals, target price Rs 641: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 13347.62 Crore) operating in P...
- Neutral on Alembic Pharmaceuticals, target price Rs 750: Motilal Oswal Financial ServicesAlembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...
- Alembic Pharma tanks 10% after flop show in Q1Shares of Alembic Pharmaceuticals declined 10 per cent to Rs 822.60, its new 52-week low, on Tuesday.
- Alembic Pharma to add 30 drugs in Indian marketVadodara-based drug maker, Alembic Pharmaceuticals will add more drugs to its domestic and international product basket this financial year.
Load More
